2023 COPD Guidelines Update

Antonio Anzueto

COPD Exacerbations: if Not, What Else?

Temple Lung Center

J. Bon

Updates in Pulmonary Function Testing

National Jewish Health

M. Mohning

Bronchiectasis: What's New and What's Next?

3rd Advanced Lung Disease: Novel Therapies and Controversies Conference

S. Devarajan

GOLD 2025 Updates: Pharmacologic Treatment

Antonio Anzueto

Triple Inhaled Therapy in COPD: Current Guidelines, Benefits/Risks, …

National Jewish Health

J. P. Woodrow

CHEST Insights 2024: Determining the Impact of COVID-19 Infection on…

CHEST Annual Meeting Insights

A. Arumairaj

Updates in Chronic Obstructive Pulmonary Disease

Duke Health

Z. Hager

Alpha One - Antitrypsin Deficiency: More Common Than You Think

Kyle Hogarth

GOLD 2023 Update: Implications for Clinical Practice

Jill Ohar

Inhaler Selection in COPD

CHEST 2022 Coverage

D. Mahler

Nontuberculous Mycobacterial Lung Disease: Epidemiology and Overview

National Jewish Health

S. Kasperbauer, D. Griffith

Precision Approaches in COPD

Matthew Moll

ATS 2022: Before We Can Run - Racial Health Disparities in Lung Dise…

Aaron Baugh

COPD: Dual Vs. Triple Therapy

Stephen Brunton

Chronic Cough, Refractory Cough, Cough Hypersensitivity Syndrome and…

National Jewish Health

R. Balkissoon

COPD: Current and Emerging Management Strategies

Brigham and Women's Hospital

C. P. Hersh

Management of Chronic Respiratory Failure With Non-Invasive Ventilat…

Michigan Medicine

P. Choi

Access to Diagnostics and Medicines for COPD in Low or Middle-Income…

Temple Lung Center

O. Beatrice Ozoh

LAMA, LABA, ICS, PDE4i, Triple, Dual, Double: Unraveling the Pharmac…

Temple Lung Center

M. Dransfield